First, let’s get one thing straight. There is no “crisis.” Now that Novartis, GlaxoSmithKline, AstraZeneca, Merck, and Sanofi have either scaled back or (in the case of GSK... Read more
“PLURIPOTENT” is a long word that means “able to do many things”. It is the technical term applied to stem cells that can generate many different sorts of bodily tissue, rather than just one... Read more
Covers such key areas as prostate cancer, schizophrenia, diabetes and Alzheimer’s Drugs giant AstraZeneca is to share 22 of its early-... Read more
Public-private partnership proposed to develop pharmaceuticals. The early stages of drug development could be freed from the shackles of intellectual property under a proposal to be tabled a... Read more